兩歧雙歧桿菌用於製備治療注意力不足過動症的藥物的用途

Translated title of the contribution: USE OF BIFIDOBACTERIUM BIFIDUM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

Liang-Jen Wang (Inventor), Chia-Yu Yang (Inventor), Ho-Chang Kuo (Inventor), WEN-JIUN CHOU (Inventor), SUNG-CHOU LI (Inventor)

Research output: Patent

Abstract

The invention provides the use of Bifidobacterium bifidum in the manufacture of a medicament for treating attention deficit hyperactivity disorder (ADHD). The administration of Bifidobacterium bifidum changes the intestinal flora of the ADHD subject and reduces the symptoms and signs.
Translated title of the contributionUSE OF BIFIDOBACTERIUM BIFIDUM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
Original languageChinese (Traditional)
IPCA61K 35/745(2015.01); A61K 35/744(2015.01); A61P 25/00(2006.01)
StatePublished - 01 10 2021

Bibliographical note

公開公告號: 2.02135844E8
Announcement ID: 2.02135844E8

Fingerprint

Dive into the research topics of 'USE OF BIFIDOBACTERIUM BIFIDUM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)'. Together they form a unique fingerprint.

Cite this